Shortsell.net [Beta]

Janux Therapeutics

JANX

Janux Therapeutics has been a target of short sellers for a while. The current short interest of 9.92% is significantly below the average of the last 12 months (13.14%).

Short Interest Trend
Share Price
Total NSP
9.92%
-0.92%
vs. last month